TCL Archive Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma July 25, 2014
TCL Archive NCI Unconventional Innovations Program releases Broad Agency Announcement. October 24, 2003
TCL Archive ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer October 9, 2009